UNSPSC 51111875: Anastrozole

This classification denotes a non-steroidal aromatase inhibitor with the molecular formula C17H19N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Z07MYW1AZ, chemically known as 1,3-benzenediacetonitrile, alpha,alpha,alpha,alpha-tetramethyl-5-(1h-1,2,4-triazol-1-ylmethyl)- but more generally known as anastrozole, which bears US NIH Compound Identifier 2187. European Medicines Agency schedules Anastrozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05502MIG.

UNSPSC 51111875 Anastrozole, a Commodity code, encompasses the supply of this aromatase inhibitor pharmaceutical to state and local government health systems, correctional facilities, and other public healthcare providers. State and local governments procure anastrozole primarily through cooperative purchasing arrangements that bundle it with broader multi-source generic pharmaceutical offerings rather than as a standalone line-item purchase. The issuing bodies soliciting under this code are state health departments and multistate cooperative purchasing alliances that aggregate demand across participating state agencies, counties, and municipalities to negotiate volume pricing with manufacturers and distributors.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued the most recent relevant opportunity on January 20, 2026—an RFP to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. This solicitation covers Oregon and other participating jurisdictions and requires vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) with awarded agreements effective July 1, 2026. Evaluation is weighted 75 percent on price competitiveness, 10 percent on fixed pricing, 5 percent on EDI capability, 5 percent on administrative fee compliance, and 5 percent on data format compliance. Vendors must maintain relationships with at least two of the three authorized wholesalers, comply with cGMP and DSCSA requirements, carry professional liability and network security insurance, and accept a 3 percent administrative fee on all contract purchases.